Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi

The development of new adjuvants enables fine modulation of the elicited immune responses. Ideally, the use of one or more adjuvants should result in the induction of a protective immune response against the specific pathogen. We have evaluated the immune response and protection against Trypanosoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Matos, Marina N., Cazorla, Silvia I., Schulze, Kai, Ebensen, Thomas, Guzmán, Carlos A., Malchiodi, Emilio L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342303/
https://www.ncbi.nlm.nih.gov/pubmed/28234897
http://dx.doi.org/10.1371/journal.pntd.0005300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342303/
https://www.ncbi.nlm.nih.gov/pubmed/28234897
http://dx.doi.org/10.1371/journal.pntd.0005300

Ejemplares similares